These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36740513)

  • 1. TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy.
    Kelliher MA; Fitzgerald KA
    Trends Immunol; 2023 Mar; 44(3):156-158. PubMed ID: 36740513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation.
    Lafont E; Draber P; Rieser E; Reichert M; Kupka S; de Miguel D; Draberova H; von Mässenhausen A; Bhamra A; Henderson S; Wojdyla K; Chalk A; Surinova S; Linkermann A; Walczak H
    Nat Cell Biol; 2018 Dec; 20(12):1389-1399. PubMed ID: 30420664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuning Apoptosis and Neuroinflammation: TBK1 Restrains RIPK1.
    Yu H; Cleveland DW
    Cell; 2018 Sep; 174(6):1339-1341. PubMed ID: 30193106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potent inhibitory role of suppressing TBK1 in RIPK1 associated cerebral ischemia-reperfusion injury.
    Yang Y; Li H; Yang C; Kong X; Wu X; Gong M; Li Y
    Brain Res; 2022 Apr; 1781():147813. PubMed ID: 35120903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade.
    Cucolo L; Chen Q; Qiu J; Yu Y; Klapholz M; Budinich KA; Zhang Z; Shao Y; Brodsky IE; Jordan MS; Gilliland DG; Zhang NR; Shi J; Minn AJ
    Immunity; 2022 Apr; 55(4):671-685.e10. PubMed ID: 35417675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIP(K)ing away immunotherapy resistance.
    Patel MA; Tavazoie SF
    Immunity; 2022 Apr; 55(4):580-582. PubMed ID: 35417670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
    Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
    Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging.
    Xu D; Jin T; Zhu H; Chen H; Ofengeim D; Zou C; Mifflin L; Pan L; Amin P; Li W; Shan B; Naito MG; Meng H; Li Y; Pan H; Aron L; Adiconis X; Levin JZ; Yankner BA; Yuan J
    Cell; 2018 Sep; 174(6):1477-1491.e19. PubMed ID: 30146158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death.
    Taft J; Markson M; Legarda D; Patel R; Chan M; Malle L; Richardson A; Gruber C; Martín-Fernández M; Mancini GMS; van Laar JAM; van Pelt P; Buta S; Wokke BHA; Sabli IKD; Sancho-Shimizu V; Chavan PP; Schnappauf O; Khubchandani R; Cüceoğlu MK; Özen S; Kastner DL; Ting AT; Aksentijevich I; Hollink IHIM; Bogunovic D
    Cell; 2021 Aug; 184(17):4447-4463.e20. PubMed ID: 34363755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting TBK1 to overcome resistance to cancer immunotherapy.
    Sun Y; Revach OY; Anderson S; Kessler EA; Wolfe CH; Jenney A; Mills CE; Robitschek EJ; Davis TGR; Kim S; Fu A; Ma X; Gwee J; Tiwari P; Du PP; Sindurakar P; Tian J; Mehta A; Schneider AM; Yizhak K; Sade-Feldman M; LaSalle T; Sharova T; Xie H; Liu S; Michaud WA; Saad-Beretta R; Yates KB; Iracheta-Vellve A; Spetz JKE; Qin X; Sarosiek KA; Zhang G; Kim JW; Su MY; Cicerchia AM; Rasmussen MQ; Klempner SJ; Juric D; Pai SI; Miller DM; Giobbie-Hurder A; Chen JH; Pelka K; Frederick DT; Stinson S; Ivanova E; Aref AR; Paweletz CP; Barbie DA; Sen DR; Fisher DE; Corcoran RB; Hacohen N; Sorger PK; Flaherty KT; Boland GM; Manguso RT; Jenkins RW
    Nature; 2023 Mar; 615(7950):158-167. PubMed ID: 36634707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era.
    Ju E; Park KA; Shen HM; Hur GM
    Exp Mol Med; 2022 Sep; 54(9):1401-1411. PubMed ID: 36171264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events.
    Delanghe T; Dondelinger Y; Bertrand MJM
    Trends Cell Biol; 2020 Mar; 30(3):189-200. PubMed ID: 31959328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory mechanisms of RIPK1 in cell death and inflammation.
    Liu Z; Chan FK
    Semin Cell Dev Biol; 2021 Jan; 109():70-75. PubMed ID: 32616439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.
    Vredevoogd DW; Kuilman T; Ligtenberg MA; Boshuizen J; Stecker KE; de Bruijn B; Krijgsman O; Huang X; Kenski JCN; Lacroix R; Mezzadra R; Gomez-Eerland R; Yildiz M; Dagidir I; Apriamashvili G; Zandhuis N; van der Noort V; Visser NL; Blank CU; Altelaar M; Schumacher TN; Peeper DS
    Cell; 2019 Jul; 178(3):585-599.e15. PubMed ID: 31303383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2.
    Wagner RN; Reed JC; Chanda SK
    Retrovirology; 2015 Aug; 12():74. PubMed ID: 26297639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death.
    Jaco I; Annibaldi A; Lalaoui N; Wilson R; Tenev T; Laurien L; Kim C; Jamal K; Wicky John S; Liccardi G; Chau D; Murphy JM; Brumatti G; Feltham R; Pasparakis M; Silke J; Meier P
    Mol Cell; 2017 Jun; 66(5):698-710.e5. PubMed ID: 28506461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-binding domain in ABIN1 is critical for regulating cell death and inflammation during development.
    Li M; Liu Y; Xu C; Zhao Q; Liu J; Xing M; Li X; Zhang H; Wu X; Wang L; Ou Y; Wu X; Zhao X; Liu H; Qiu L; Li F; Li J; Rong W; Luo Y; Deng J; Wang X; Wang Z; Zhao Y; Lv A; Li Q; Zhang H
    Cell Death Differ; 2022 Oct; 29(10):2034-2045. PubMed ID: 35430614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma.
    Lomphithak T; Choksi S; Mutirangura A; Tohtong R; Tencomnao T; Usubuchi H; Unno M; Sasano H; Jitkaew S
    Cell Commun Signal; 2020 Oct; 18(1):161. PubMed ID: 33036630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting TANK-binding kinase 1 (TBK1) in cancer.
    Revach OY; Liu S; Jenkins RW
    Expert Opin Ther Targets; 2020 Nov; 24(11):1065-1078. PubMed ID: 32962465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Roles for RIPK1 and RIPK3 in Pathogen-Induced Cell Death and Host Immunity.
    Saleh D; Degterev A
    Curr Top Microbiol Immunol; 2017; 403():37-75. PubMed ID: 26385769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.